CAU Scholar's Space: Min, Kyung Hoon

Detailed Information

Min, Kyung Hoon (민경훈)

대학원 (글로벌혁신신약학과)

Research Area

Tel 02-820-5599
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Small molecule:8||Pglycoprotein:3||Multidrug resistance:3||Isoxazole:3||Click chemistry:2||Obovatol:2||MESSA/DX5:2||Small molecule inhibitor:2||Small molecules:2||Solidphase synthesis:2||Xlinked adrenoleukodystrophy:2||Kinase inhibitor:2||Astrocyte:2||Phagocytosis:2||TAK1:2||Macrophage:2||thienopyrimidine:2||EGFR:2||Melanogenesis:2||Pyrimidine:2||HER2:2||Quinazoline:2||Combinatorial chemistry:2||Neural stem cell:2||Benzopyranyl thiourea:1||Benzopyranyl urea:1||Biaryl amide compounds:1||Biarylamide:1||Bioisostere:1||Bone marrow derived dendritic cells:1||CB1R:1||CD34:1||CSF1R:1||CYP3A4:1||Cancer:1||Cathepsin S:1||Cathepsin S inhibitor:1||Chimeric molecule:1||Chirality:1||Chlorambucil:1||Colon cancer:1||Coumarins:1||DGAT1:1||Dectin1:1||Decursin:1||Derivatives:1||Diarylalkyl amides:1||Differentiation:1||Docking simulation:1||EGFR tyrosine kinase inhibitors:1||ELFEMF:1||Enzyme inhibitors:1||Epidermal growth factor receptor:1||Epidermal growth factor receptor (EGFR):1||Erlotinib:1||ExoU:1||Eyelash extension:1||Eyelashes Health Problems:1||Gproteincoupled receptors:1||GHSR:1||Gefitinib:1||Heterocycles:1||Hinge binder:1||Human embryonic stem cells:1||Imidazopyrazine:1||Imidazothiazole:1||Inflammation:1||Inhibitor:1||LRRK2 inhibitor:1||Lovastatin:1||MC4R:1||MCH1R:1||MDRMultidrug resistance:1||MER:1||ML106:1||MLV0901:1||Malonamide:1||Methyl gallate:1||MicroRNA:1||Multidrug resistance (MDR):1||Mutant selective kinase inhibitor:1||Myeloid cells:1||N,N,N′,N′tetramethyl thiourea:1||N18D3:1||NFkB:1||NFkappa B:1||NMR spectroscopy:1||NO inhibition:1||Neural progenitor cell:1||Nitric oxide:1||Novel ligand:1||PGlycoprotein:1||Pglycoprotein (Pgp):1||Pgp:1||PDGF:1||Prantschimgin:1||Proline:1||Proline analogues:1||Pseudomonas aeruginosa:1||Quinazoline analogues:1||RAW 264.7:1||Reactive oxygen species:1||Retinoic acid receptor alpha:1||Rho GTPase:1||Selectivity:1||Selenium:1||Sensory neurons:1||Structureactivity relationship:1||Structurebased virtual screening:1||Sulfonamides:1||TAM familty:1||TGR5:1||TRPV1:1||TRPV1 antagonists:1||TRPV4:1||Tacc3:1||Traceless support:1||Transcription factor hijacking:1||Tyrosinase:1||Tyrosine kinase inhibitor:1||Tyrosine kinase inhibitors:1||Urea:1||VEGFR2:1||Vanilloid receptor:1||Vascular differentiation:1||Vascular smooth muscle cell:1||Very long chain fatty acids:1||Vinyl sulfone:1||Xray crystallography:1||Zymosan:1||alpha1,2,3Triazoloamides:1||antiobesity agents:1||cannabinoid receptor 1:1||cytochrome P450:1||dependence and abuse potential:1||derivatives:1||highresolution quadrupoleOrbitrap mass spectrometry:1||homology modeling:1||imidazopyridine:1||inflammatory cytokine:1||kinase inhibitor:1||liver X receptor:1||macrophage:1||multiple linear regression:1||obesity:1||partial least squares regression:1||peroxiredoxin1:1||phase 1 metabolism:1||pyrrolopyrimidine:1||quantitative structureactivity relationship:1||resveratrol:1||reversible covalent chemistry:1||small molecule:1||small molecule inhibitor:1||small molecules:1||synthetic cannabinoids:1||type 2 diabetes:1||very long chain fatty acids:1||1,3,4Oxadiazole:1||virtual screening:1||1,3,4oxadiazine:1||12(S)HPETE:1||2,4dimethoxynitrobenzene:1||2cyanoacrylamide:1||25hydroxycholesterol:1||5Carbamoylthiazole:1||ABC transporter:1||Acanthoic acid analog:1||Adamantane:1||Adult neurogenesis:1||Aging:1||Agonist:1||Akt phosphorylation:1||Akt phosphorylation inhibitors:1||Alkylphosphocholines:1||Alkylphospholipids (APL):1||Alltrans retinoic acid:1||Antagonist:1||Antiplatelet activity:1||Antiproliferartive agents:1||Aromatic nucleophilic substitution:1||Atherosclerosis:1||Axl:1||

STATISTICS: Total View :6,845,644; Today View :5,303

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE